Replies to post #121191 on Anavex Life Sciences Corp (AVXL)

[OFP]

I've been saying this all along, with almost every clinical-stage biotech. They are experts at hedging. They have to be, to stay alive financially.

I know you have...and despite that it seems a constant here that someone points to a statement as evidence of a global truth with no understanding of the basis.

Homeostasis (basis = preclinical data overshone by DZP) and dose dependency (basis = poor 5 week data which is now nearly irrelevant). The company has milked those for all their worth and people still point to them as if they are present as an established and relevant clinical effect.